Advertisement

Current Heart Failure Reports

, Volume 13, Issue 1, pp 20–29 | Cite as

Complex Care Options for Patients With Advanced Heart Failure Approaching End of Life

  • Sara E. Wordingham
  • Colleen K. McIlvennan
  • J. Nicholas Dionne-Odom
  • Keith M. Swetz
Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (A Hasan, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise

Abstract

Care for patients with advanced cardiac disease continues to evolve in a complex milieu of therapeutic options, advanced technological interventions, and efforts at improving patient-centered care and shared decision-making. Despite improvements in quality of life and survival with these interventions, optimal supportive care across the advanced illness trajectory remains diverse and heterogeneous. Herein, we outline challenges in prognostication, communication, and caregiving in advanced heart failure and review the unique needs of patients who experience frequent hospitalizations, require chronic home inotropic support, and who have implantable cardioverter-defibrillators and mechanical circulatory support in situ, to name a few.

Keywords

Ventricular assist device Heart failure Mechanical circulatory support Advance care planning Caregiver Inotropes Palliative care End of life 

Abbreviations

EOL

End of life

QOL

Quality of life

ICD

Implantable cardioverter-defibrillator

LVAD

Left ventricular assist device

HF

Heart failure

DT

Destination therapy

MCS

Mechanical circulatory support

CMS

Centers for Medicare & Medicaid Services

Notes

Compliance with Ethical Standards

Conflict of Interest

Sara E. Wordingham and Colleen K. McIlvennan declare that they have no conflict of interest.

J. Nicholas Dionne-Odom is a postdoctoral fellow supported by a National Palliative Care Research Center Career Development Award.

Keith M. Swetz has received salary support from the US Federal Government (Department of Veterans Affairs; Birmingham Veterans Affairs Medical Center).

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2015. doi: 10.1161/CIR.0000000000000350.Google Scholar
  2. 2.
    Murray SA, Boyd K, Kendall M, Worth A, Benton TF, Clausen H. Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. BMJ. 2002;325(7370):929.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.••
    Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–52. AHA framework on communication and shared decision-making in advanced heart failure.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.•
    Miller LW, Guglin M. Patient selection for ventricular assist devices: a moving target. J Am Coll Cardiol. 2013;61(12):1209–21. Review of key factors in patient selection for MCS.CrossRefPubMedGoogle Scholar
  5. 5.
    Swetz KM, Stulak JM, Dunlay SM, Gafford EF. Management of advance heart failure in the elderly: ethics, economics, and resource allocation in the technological area. Cardiol Res Pract. 2012;2012:524961.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Evangelista LS, Liao S, Motie M, De Michelis N, Ballard-Hernandez J, Lombardo D. Does the type and frequency of palliative care services received by patients with advanced heart failure impact symptom burden? J Palliat Med. 2014;17(1):75–9.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Ury WA, Berkman CS, Weber CM, Pignotti MG, Leipzig RM. Assessing medical students’ training in end-of-life communication: a survey of interns at one urban teaching hospital. Acad Med. 2003;78(5):530–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Dunlay SM, Foxen JL, Cole T, Feely MA, Loth AR, Strand JJ, et al. A survey of clinician attitudes and self-reported practices regarding end-of-life care in heart failure. Palliat Med. 2015;29(3):260–7.CrossRefPubMedGoogle Scholar
  9. 9.•
    Dunlay SM, Strand JJ. How to discuss goals of care with patients. Trends Cardiovasc Med. 2016;26(1):36–43. Recent review addressing communication strategies when discussing HF care with patients and caregivers.Google Scholar
  10. 10.
    Apatira L, Boyd EA, Malvar G, Evans LR, Luce JM, Lo B, et al. Hope, truth, and preparing for death: perspectives of surrogate decision makers. Ann Intern Med. 2008;149(12):861–8.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Golin CE, Wenger NS, Liu H, Dawson NV, Teno JM, Desbiens NA, et al. A prospective study of patient-physician communication about resuscitation. J Am Geriatr Soc. 2000;48(5 Suppl):S52–60.CrossRefPubMedGoogle Scholar
  12. 12.
    Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665–73.PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.••
    Whellan DJ, Goodlin SJ, Dickinson MG, Heidenreich PA, Jaenicke C, Stough WG, et al. End-of-life care in patients with heart failure. J Card Fail. 2014;20(2):121–34. Broad review of end of life care in heart failure including communication, symptom management, advanced therapies and advance care planning.CrossRefPubMedGoogle Scholar
  14. 14.
    Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. BMJ. 2010;14(341):c5146.CrossRefGoogle Scholar
  15. 15.•
    Matlock DD, Vigil D, Jenkins A, Mellis K, Varosy P, Masoudi F et al. Implantable cardioverter defibrillator (ICD): a decision aid for patients considering ICD therapy for primary prevention. University of Colorado, School of Medicine. 2013. https://patientdecisionaid.org/icd/. Accessed 2016 Jan 12. A decision aid for patients considering ICD therapy.
  16. 16.•
    Allen LA, Matlock DD, Thompson JS, McIlvennan CK, Jenkins AR. A decision aid for left ventricular assist device (LVAD) for destination therapy: a device for patients with advanced heart failure. University of Colorado, School of Medicine. 2015. https://patientdecisionaid.org/assets/pdf/lvad_ptda2015.pdf. Accessed 2016 Jan 12. A decision aid for patients considering DT-LVAD .
  17. 17.
    Coylewright M, Mack MJ, Holmes Jr DR, O’Gara PT. A call for an evidence-based approach to the heart team for patients with severe aortic stenosis. J Am Coll Cardiol. 2015;65(14):1472–80.CrossRefPubMedGoogle Scholar
  18. 18.
    Teno JM, Gruneir A, Schwartz Z, Nanda A, Wetle T. Association between advance directives and quality of end-of-life care: a national study. J Am Geriatr Soc. 2007;55(2):189–94.CrossRefPubMedGoogle Scholar
  19. 19.•
    Swetz KM, Freeman MR, AbouEzzeddine OF, Carter KA, Boilson BA, Ottenberg AL, et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc. 2011;86(6):493–500. Sentinel study of proactive integration of palliative care into the care of patients receiving DT-LVAD to improve advance care planning.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    McIlvennan CK, Allen LA, Nowels C, Brieke A, Cleveland JC, Matlock DD. Decision making for destination therapy left ventricular assist devices: “there was no choice” versus “I thought about it an awful lot”. Circ Cardiovasc Qual Outcomes. 2014;7(3):374–80.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Ottenberg AL, Cook KE, Topazian RJ, Mueller LA, Mueller PS, Swetz KM. Choices for patients “without a choice”: interviews with patients who received a left ventricular assist device as destination therapy. Circ Cardiovasc Qual Outcomes. 2014;7(3):368–73.CrossRefPubMedGoogle Scholar
  22. 22.
    Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, et al. Discordance between patient-predicted and model-predicted life expectancy among ambulatory heart failure patients. JAMA. 2008;299(21):2533–42.PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Warraich HJ, Mukamal K, Allen L, Ship A, Kociol R. Physician estimates of prognosis in heart failure. J Am Coll Cardiol. 2014;63(12):A951. doi: 10.1016/s0735-1097(14)60951-7.CrossRefGoogle Scholar
  24. 24.
    Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54(5):386–96.CrossRefPubMedGoogle Scholar
  25. 25.•
    Hashim T, Sanam K, Revilla-Martinez M, Morgan CJ, Talaj JA, Pamboukian SV, et al. Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure. Circ Heart Fail. 2015;8(5):880–6. Recent study looking at inotrope use and effect on survival with most up-to-date data on survival with inotropes.CrossRefPubMedGoogle Scholar
  26. 26.
    Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S, et al. Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol. 2009;53(4):334–42.CrossRefPubMedGoogle Scholar
  27. 27.
    Bakitas M, Macmartin M, Trzepkowski K, Robert A, Jackson L, Brown JR, et al. Palliative care consultations for heart failure patients: how many, when, and why? J Card Fail. 2013;19(3):193–201.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Fitzsimons D, Mullan D, Wilson JS, Conway B, Corcoran B, Dempster M, et al. The challenge of patients’ unmet palliative care needs in the final stages of chronic illness. Palliat Med. 2007;21(4):313–22.CrossRefPubMedGoogle Scholar
  29. 29.
    Christakis NA, Iwashyna TJ. Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med. 1998;158(21):2389–95.CrossRefPubMedGoogle Scholar
  30. 30.
    Keating NL, Landrum MB, Rogers SO, Baum SK, Virnig BA, Huskamp HA, et al. Physician factors associated with discussions about end-of-life care. Cancer. 2010;116(4):998–1006.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ. 2006;333(7574):886.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Smith TJ, Dow LA, Virago E, Khatcheressian J, Lyckholm LJ, Matsuyama R. Giving honest information to patients with advanced cancer maintains hope. Oncology (Williston Park). 2010;24(6):521–5.Google Scholar
  33. 33.•
    Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–19. Most recently updated data projecting direct and total costs associated with HF in the United States with discussion of implications.PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–28.CrossRefPubMedGoogle Scholar
  35. 35.
    Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157(1):99–104.CrossRefPubMedGoogle Scholar
  36. 36.
    Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, et al. Implantable cardioverter-defibrillator use in older adults: proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes. 2015;8(4):437–46.CrossRefPubMedGoogle Scholar
  37. 37.
    Swetz KM, Mansel JK. Ethical issues and palliative care in the cardiovascular intensive care unit. Cardiol Clin. 2013;31(4):657–68.CrossRefPubMedGoogle Scholar
  38. 38.
    Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.CrossRefPubMedGoogle Scholar
  39. 39.
    Centers for Medicare & Medicaid Services. Home Parenteral Inotropic Therapy: Data Collection Form. n.d. http://downloads.cms.gov/medicare-coverage-database/lcd_attachments/5044_15/HomeParenteralInotropicTherapyDataCollectionForm.pdf. Accessed 12 January 2016.
  40. 40.
    Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail. 2003;9(3):180–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Centers for Medicare & Medicaid Services. Medicare Program; FY 2016 hospice wage index and payment rate update and hospice quality reporting requirements. Final rule. Fed Regist. 2015;80(151):47141–207.Google Scholar
  42. 42.
    Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7):1008–26.CrossRefPubMedGoogle Scholar
  43. 43.
    Kirkpatrick JN, Gottlieb M, Sehgal P, Patel R, Verdino RJ. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol. 2012;109(1):91–4.CrossRefPubMedGoogle Scholar
  44. 44.
    Tajouri TH, Ottenberg AL, Hayes DL, Mueller PS. The use of advance directives among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2012;35(5):567–73.CrossRefPubMedGoogle Scholar
  45. 45.
    Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141(11):835–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, et al. “That’s like an act of suicide” patients’ attitudes toward deactivation of implantable defibrillators. J Gen Intern Med. 2008;23 Suppl 1:7–12.PubMedCentralCrossRefPubMedGoogle Scholar
  47. 47.
    Sherazi S, McNitt S, Aktas MK, Polonsky B, Shah AH, Moss AJ, et al. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy. Pacing Clin Electrophysiol. 2013;36(10):1273–9.PubMedGoogle Scholar
  48. 48.
    Goldstein NE, Kalman J, Kutner JS, Fromme EK, Hutchinson MD, Lipman HI, et al. A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges behind the working to improve discussions about defibrillator management trial. J Pain Symptom Manag. 2014;48(6):1236–46.CrossRefGoogle Scholar
  49. 49.
    Lampropulos JF, Kim N, Wang Y, Desai MM, Barreto-Filho JA, Dodson JA, et al. Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011. Open Heart. 2014;1(1):e000109.PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.•
    McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail. 2014;7(6):1003–13. Summary of clinical outcomes in LVAD, highlighting complex trade offs of survival and post-implantation morbidity.PubMedCentralCrossRefPubMedGoogle Scholar
  51. 51.
    Vitale CA, Chandekar R, Rodgers PE, Pagani FD, Malani PN. A call for guidance in the use of left ventricular assist devices in older adults. J Am Geriatr Soc. 2012;60(1):145–50.CrossRefPubMedGoogle Scholar
  52. 52.
    Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–51.CrossRefPubMedGoogle Scholar
  53. 53.
    Modified: ventricular assist device destination therapy requirements. Jt Comm Perspect. 2014; 34(2):6-7.Google Scholar
  54. 54.
    Centers for Medicare & Medicaid Services. Ventricular assist devices for bridge-to-transplant and destination therapy. In: Medicare Learning Network (MLN) Matters. 2013. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/MM8803.pdf. Accessed 2016 January 12.
  55. 55.
    Kiernan MS, Joseph SM, Katz JN, Kilic A, Rich JD, Tallman MP, et al. Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers. Circ Heart Fail. 2015;8(3):629–35.CrossRefPubMedGoogle Scholar
  56. 56.••
    Swetz KM, Kamal AH, Matlock DD, Dose AM, Borkenhagen LS, Kimeu AK, et al. Preparedness planning before mechanical circulatory support: a “how-to” guide for palliative medicine clinicians. J Pain Symptom Manag. 2014;47(5):926–35. Detailed description of an innovative approach to advance care planning in DT-LVAD.CrossRefGoogle Scholar
  57. 57.
    Bruce CR, Pena A, Kusin BB, Allen NG, Smith ML, Majumder MA. An embedded model for ethics consultations: characteristics, outcomes, and challenges. AJOB Emperical Bioethics. 2014;5(3):8–18.CrossRefGoogle Scholar
  58. 58.
    Swetz KM, Mueller PS, Ottenberg AL, Dib C, Freeman MR, Sulmasy DP. The use of advance directives among patients with left ventricular assist devices. Hosp Pract. 2011;39(1):78–87.CrossRefGoogle Scholar
  59. 59.
    Wordingham SE, Kasten RM, Swetz KM. Total artificial heart #296. J Palliat Med. 2015;18(11):985–6.CrossRefPubMedGoogle Scholar
  60. 60.
    Bruce CR, Allen NG, Fahy BN, Gordon HL, Suarez EE, Bruckner BA. Challenges in deactivating a total artificial heart for a patient with capacity. Chest. 2014;145(3):625–31.CrossRefPubMedGoogle Scholar
  61. 61.
    Gafford EF, Luckhardt AJ, Swetz KM. Deactivation of a left ventricular assist device at the end of life #269. J Palliat Med. 2013;16(8):980–2.CrossRefPubMedGoogle Scholar
  62. 62.•
    Mueller PS, Swetz KM, Freeman MR, Carter KA, Crowley ME, Severson CJ, et al. Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc. 2010;85(9):791–7. One of the initial ethical analyses supporting VAD withdrawal as equivalent to that of other life-sustaining interventions.Google Scholar
  63. 63.
    Sulmasy DP. Within you/without you: biotechnology, ontology, and ethics. J Gen Intern Med. 2008;23 Suppl 1:69–72.PubMedCentralCrossRefPubMedGoogle Scholar
  64. 64.
    Swetz KM, Wordingham SE, Armstrong MH, Koepp KE, Ottenberg AL. Hospice and palliative medicine clinician views of deactivation of ventricular assist devices at the end of life. J Pain Symptom Manag. 2015;50(2):e6–8.CrossRefGoogle Scholar
  65. 65.
    Swetz KM, Cook KE, Ottenberg AL, Chang N, Mueller PS. Clinicians’ attitudes regarding withdrawal of left ventricular assist devices in patients approaching the end of life. Eur J Heart Fail. 2013;15(11):1262–6.PubMedCentralCrossRefPubMedGoogle Scholar
  66. 66.••
    Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al. The 2013 international society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157–87. Most recent ISHLT guidelines for MCS.CrossRefPubMedGoogle Scholar
  67. 67.•
    Brush S, Budge D, Alharethi R, McCormick AJ, MacPherson JE, Reid BB, et al. End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant. 2010;29(12):1337–41. Study of end of life in VAD patients incorporating a multidisciplinary approach and open a priori dialogue.CrossRefPubMedGoogle Scholar
  68. 68.
    Centers for Disease Control. Underlying cause of death, 1999–2014. 2016. http://wonder.cdc.gov/ucd-icd10.html. Accessed 12 January 2016.
  69. 69.
    Davidson PM, Abernethy AP, Newton PJ, Clark K, Currow DC. The caregiving perspective in heart failure: a population based study. BMC Health Serv Res. 2013;13:342.PubMedCentralCrossRefPubMedGoogle Scholar
  70. 70.
    Joo H, Fang J, Losby JL, Wang G. Cost of informal caregiving for patients with heart failure. Am Heart J. 2015;169(1):142–8.PubMedCentralCrossRefPubMedGoogle Scholar
  71. 71.
    Fang JC, Ewald GA, Allen LA, Butler J, Westlake Canary CA, Colvin-Adams M, et al. Advanced (stage D) heart failure: a statement from the Heart Failure Society of America guidelines committee. J Card Fail. 2015;21(6):519–34.CrossRefPubMedGoogle Scholar
  72. 72.
    Hwang B, Luttik ML, Dracup K, Jaarsma T. Family caregiving for patients with heart failure: types of care provided and gender differences. J Card Fail. 2010;16(5):398–403.CrossRefPubMedGoogle Scholar
  73. 73.
    Pressler SJ, Gradus-Pizlo I, Chubinski SD, Smith G, Wheeler S, Sloan R, et al. Family caregivers of patients with heart failure: a longitudinal study. J Cardiovasc Nurs. 2013;28(5):417–28.CrossRefPubMedGoogle Scholar
  74. 74.
    Wingham J, Frost J, Britten N, Jolly K, Greaves C, Abraham C, et al. Needs of caregivers in heart failure management: a qualitative study. Chronic Illn. 2015;11(4):304–19.PubMedCentralCrossRefPubMedGoogle Scholar
  75. 75.
    Burke RE, Jones J, Ho PM, Bekelman DB. Caregivers’ perceived roles in caring for patients with heart failure: what do clinicians need to know? J Card Fail. 2014;20(10):731–8.CrossRefPubMedGoogle Scholar
  76. 76.
    Saunders MM. Factors associated with caregiver burden in heart failure family caregivers. West J Nurs Res. 2008;30(8):943–59.CrossRefPubMedGoogle Scholar
  77. 77.
    Doherty LC, Fitzsimons D, McIlfatrick SJ. Carers’ needs in advanced heart failure: a systematic narrative review. Eur J Cardiovasc Nurs. 2015. doi: 10.1177/1474515115585237.PubMedGoogle Scholar
  78. 78.
    Stromberg A, Luttik ML. Burden of caring: risks and consequences imposed on caregivers of those living and dying with advanced heart failure. Curr Opin Support Palliat Care. 2015;9(1):26–30.CrossRefPubMedGoogle Scholar
  79. 79.
    O’Leary N. The comparative palliative care needs of those with heart failure and cancer patients. Curr Opin Support Palliat Care. 2009;3(4):241–6.CrossRefPubMedGoogle Scholar
  80. 80.••
    MacKenzie MA, Buck HG, Meghani SH, Riegel B. Unique correlates of heart failure and cancer caregiver satisfaction with hospice care. J Pain Symptom Manag. 2016;51(1):71–8. Large retrospective cohort study of national database with over 7300 caregivers of patients with HF and over 23000 caregivers for patients with cancer identifying unique issues with hospice care for patients with HF.CrossRefGoogle Scholar
  81. 81.
    Cheang MH, Rose G, Cheung CC, Thomas M. Current challenges in palliative care provision for heart failure in the UK: a survey on the perspectives of palliative care professionals. Open Heart. 2015;2(1):e000188.PubMedCentralCrossRefPubMedGoogle Scholar
  82. 82.
    Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ. Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev. 2013;6:CD007760.PubMedGoogle Scholar
  83. 83.••
    Quill TE, Abernethy AP. Generalist plus specialist palliative care—creating a more sustainable model. N Engl J Med. 2013;368(13):1173–5. Groundbreaking commentary about recommending palliative care skills for all providers and what the subspecialist palliative care skill set involves.CrossRefPubMedGoogle Scholar
  84. 84.
    Schwarz ER, Baraghoush A, Morrissey RP, Shah AB, Shinde AM, Phan A, et al. Pilot study of palliative care consultation in patients with advanced heart failure referred for cardiac transplantation. J Palliat Med. 2012;15(1):12–5.CrossRefPubMedGoogle Scholar
  85. 85.
    Dionne-Odom JN, Azuero A, Lyons KD, Hull JG, Tosteson T, Li Z, et al. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1446–52.CrossRefPubMedGoogle Scholar
  86. 86.
    National Hospice and Palliative Care Organization. NHPCO’s facts and figures-hospice care in America. 2015. http://www.nhpco.org/sites/default/files/public/Statistics_Research/2015_Facts_Figures.pdf. Accessed 12 January 2016.
  87. 87.•
    Lum HD, Jones J, Lahoff D, Allen LA, Bekelman DB, Kutner JS, et al. Unique challenges of hospice for patients with heart failure: a qualitative study of hospice clinicians. Am Heart J. 2015;170(3):524–30. Discusses perspectives of hospice clinicians regarding unique challenges encountered with hospice, EOL and HF.CrossRefPubMedGoogle Scholar
  88. 88.•
    Dumanovsky T, Augustin R, Rogers M, Lettang K, Meier DE, Morrison RS. The growth of palliative care in U.S. hospitals: a status report. J Palliat Med. 2016;19(1):8–15. Newest data published regarding status and availability of palliative care at hospitals in the U.S. PubMedCentralCrossRefPubMedGoogle Scholar
  89. 89.
    Lum HD, Horney C, Koets D, Kutner JS, Matlock DD. Availability of heart failure medications in hospice care. Am J Hosp Palliat Care. 2015. doi: 10.1177/1049909115603689.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Sara E. Wordingham
    • 1
  • Colleen K. McIlvennan
    • 2
  • J. Nicholas Dionne-Odom
    • 3
  • Keith M. Swetz
    • 4
  1. 1.Department of Medicine, Division of Hematology/Oncology, Palliative MedicineMayo ClinicPhoenixUSA
  2. 2.Section of Advanced Heart Failure and Transplantation, Division of CardiologyUniversity of Colorado School of Medicine, Aurora and Colorado Cardiovascular Outcomes Research ConsortiumDenverUSA
  3. 3.School of NursingUniversity of Alabama at BirminghamBirminghamUSA
  4. 4.Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research, Education, and Clinical Center; Birmingham VA Medical Center; and Center for Palliative and Supportive CareUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations